Japanese encephalitis virus expands regulatory T cells by increasing the expression of PD-L1 on dendritic cells

European Journal of Immunology

Volumn 44, Issue 5, 2014, Pages 1363-1374

  Gupta, Nimesh ^a   Hegde, Pushpa ^a,b   Lecerf, Maxime ^a   Nain, Minu ^c   Kaur, Manpreet ^c   Kalia, Manjula ^c   Vrati, Sudhanshu ^c,d   Bayry, Jagadeesh ^a,e   Lacroix Desmazes, Sébastien ^a,e   Kaveri, Srini V ^a,e  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b UNIVERSITÉ DE TECHNOLOGIE DE COMPIÈGNE   (France)

^c Translational Health Science and Technology Institute   (India)

^d NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^e Genetic Research Centre India   (India)

Author keywords

Host pathogen interactions; Immune evasion; Infectious diseases; PD L1; Regulatory T cells

Indexed keywords

CD4 ANTIGEN; PROGRAMMED DEATH 1 LIGAND 1;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; LYMPHOCYTE FUNCTION; MIXED LYMPHOCYTE REACTION; MONOCYTE; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH1 CELL; ULTRAVIOLET RADIATION; VIROGENESIS; VIRUS REPLICATION;

HOST-PATHOGEN INTERACTIONS; IMMUNE EVASION; INFECTIOUS DISEASES; PD-L1; REGULATORY T CELLS;

ANTIGENS, CD274; ANTIGENS, DIFFERENTIATION; CELL PROLIFERATION; DENDRITIC CELLS; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNE EVASION; MALE; MONOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 84899563272     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343701     Document Type: Article

References (69)

1. Van den Hurk, A. F., Ritchie, S. A. and Mackenzie, J. S., Ecology and geographical expansion of Japanese encephalitis virus. Annu. Rev. Entomol. 2009. 54: 17-35.
2. Mackenzie, J. S., Gubler, D. J. and Petersen, L. R., Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat. Med. 2004. 10: S98-S109.
3. Gould, E. A. and Solomon, T., Pathogenic flaviviruses. Lancet 2008. 371: 500-509.
4. Gould, E. A., Solomon, T. and Mackenzie, J. S., Does antiviral therapy have a role in the control of Japanese encephalitis? Antiviral Res. 2008. 78: 140-149.
5. Turtle, L., Griffiths, M. J. and Solomon, T., Encephalitis caused by flaviviruses. QJM 2012. 105: 219-223.
6. Lai, C. Y., Ou, Y. C., Chang, C. Y., Pan, H. C., Chang, C. J., Liao, S. L., Su, H. L. et al., Endothelial Japanese encephalitis virus infection enhances migration and adhesion of leukocytes to brain microvascular endothelia via MEK-dependent expression of ICAM1 and the CINC and RANTES chemokines. J. Neurochem. 2012. 123: 250-261.
7. Mathur, A., Khanna, N. and Chaturvedi, U. C., Breakdown of blood-brain barrier by virus-induced cytokine during Japanese encephalitis virus infection. Int. J. Exp. Pathol. 1992. 73: 603-611.
8. Gupta, N., Lomash, V. and Rao, P. V., Expression profile of Japanese encephalitis virus induced neuroinflammation and its implication in disease severity. J. Clin. Virol. 2010. 49: 4-10.
9. Biswas, S. M., Kar, S., Singh, R., Chakraborty, D., Vipat, V., Raut, C. G., Mishra, A. C. et al., Immunomodulatory cytokines determine the outcome of Japanese encephalitis virus infection in mice. J. Med. Virol. 2010. 82: 304-310.
10. Mishra, M. K., Dutta, K., Saheb, S. K. and Basu, A., Understanding the molecular mechanism of blood-brain barrier damage in an experimental model of Japanese encephalitis: correlation with minocycline administration as a therapeutic agent. Neurochem. Int. 2009. 55: 717-723.
11. Burke, D. S., Nisalak, A. and Gentry, M. K., Detection of flavivirus antibodies in human serum by epitope-blocking immunoassay. J. Med. Virol. 1987. 23: 165-173.
12. Libraty, D. H., Nisalak, A., Endy, T. P., Suntayakorn, S., Vaughn, D. W. and Innis, B. L., Clinical and immunological risk factors for severe disease in Japanese encephalitis. Trans. R. Soc. Trop. Med. Hyg. 2002. 96: 173-178.
13. McCallum, J. D., Japanese encephalitis in southeastern Nepal: clinical aspects in the 1986 epidemic. J. R. Army Med. Corps 1991. 137: 8-13.
14. Goncalvez, A. P., Chien, C. H., Tubthong, K., Gorshkova, I., Roll, C., Donau, O., Schuck, P. et al., Humanized monoclonal antibodies derived from chimpanzee Fabs protect against Japanese encephalitis virus in vitro and in vivo. J. Virol. 2008. 82: 7009-7021.
15. Gupta, A. K., Lad, V. J. and Koshy, A. A., Protection of mice against experimental Japanese encephalitis virus infections by neutralizing anti-glycoprotein E monoclonal antibodies. Acta. Virol. 2003. 47: 141-145.
16. Kimura-Kuroda, J. and Yasui, K., Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies. J. Immunol. 1988. 141: 3606-3610.
17. Zhang, M. J., Wang, M. J., Jiang, S. Z. and Ma, W. Y., Passive protection of mice, goats, and monkeys against Japanese encephalitis with monoclonal antibodies. J. Med. Virol. 1989. 29: 133-138.
18. + Th2 response and associated immunoprotection in an adoptive-transfer murine model. J. Gen. Virol. 2009. 90: 818-826.
19. + T cells to recovery from infection in a murine model of Japanese encephalitis. J. Virol. 2011. 85: 5446-5455.
20. Mathur, A., Rawat, S. and Chaturvedi, U. C., Suppressor T cells for delayed-type hypersensitivity to Japanese encephalitis virus. Immunology 1984. 52: 395-402.
21. Mathur, A., Kulshreshtha, R., Rawat, S. and Chaturvedi, U. C., Memory suppressor T cells in latent Japanese encephalitis virus infection. Immunology 1987. 60: 71-74.
22. Zhu, J., Yamane, H. and Paul, W. E., Differentiation of effector CD4 T cell populations (*). Annu. Rev. Immunol. 2010. 28: 445-489.
23. Aleyas, A. G., George, J. A., Han, Y. W., Rahman, M. M., Kim, S. J., Han, S. B., Kim, B. S. et al., Functional modulation of dendritic cells and macrophages by Japanese encephalitis virus through MyD88 adaptor molecule-dependent and -independent pathways. J. Immunol. 2009. 183: 2462-2474.
24. Sooryanarain, H., Ayachit, V. and Gore, M., Activated CD56(+) lymphocytes (NK+NKT) mediate immunomodulatory and anti-viral effects during Japanese encephalitis virus infection of dendritic cells in-vitro. Virology 2012. 432: 250-260.
25. Wang, K. and Deubel, V., Mice with different susceptibility to Japanese encephalitis virus infection show selective neutralizing antibody response and myeloid cell infectivity. PLoS One 2011. 6: e24744.
26. Van Kooyk, Y. and Geijtenbeek, T. B., DC-SIGN: escape mechanism for pathogens. Nat. Rev. Immunol. 2003. 3: 697-709.
27. Tassaneetrithep, B., Burgess, T. H., Granelli-Piperno, A., Trumpfheller, C., Finke, J., Sun, W., Eller, M. A. et al., DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 2003. 197: 823-829.
28. Belkaid, Y., Regulatory T cells and infection: a dangerous necessity. Nat. Rev. Immunol. 2007. 7: 875-888.
29. Belkaid, Y. and Tarbell, K., Regulatory T cells in the control of host-microorganism interactions (*). Annu. Rev. Immunol. 2009. 27: 551-589.
30. Francisco, L. M., Salinas, V. H., Brown, K. E., Vanguri, V. K., Freeman, G. J., Kuchroo, V. K. and Sharpe, A. H., PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J. Exp. Med. 2009. 206: 3015-3029.
31. Keir, M. E., Liang, S. C., Guleria, I., Latchman, Y. E., Qipo, A., Albacker, L. A., Koulmanda, M. et al., Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 2006. 203: 883-895.
32. Chase, A. J., Medina, F. A. and Munoz-Jordan, J. L., Impairment of CD4+ T cell polarization by dengue virus-infected dendritic cells. J. Infect. Dis. 2011. 203: 1763-1774.
33. + regulatory T cells. Proc. Natl. Acad. Sci. USA 2007. 104: 18169-18174.
34. Rinaldo, C. R., Jr. and Piazza, P., Virus infection of dendritic cells: portal for host invasion and host defense. Trends Microbiol. 2004. 12: 337-345.
35. Carbone, F. R. and Heath, W. R., The role of dendritic cell subsets in immunity to viruses. Curr. Opin. Immunol. 2003. 15: 416-420.
36. Yang, K. D., Yeh, W. T., Chen, R. F., Chuon, H. L., Tsai, H. P., Yao, C. W. and Shaio, M. F., A model to study neurotropism and persistency of Japanese encephalitis virus infection in human neuroblastoma cells and leukocytes. J. Gen. Virol. 2004. 85: 635-642.
37. Steinman, R. M., Hawiger, D. and Nussenzweig, M. C., Tolerogenic dendritic cells. Annu. Rev. Immunol. 2003. 21: 685-711.
38. Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I. and Banchereau, J., Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 1994. 180: 1263-1272.
39. Fujii, S., Liu, K., Smith, C., Bonito, A. J. and Steinman, R. M., The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J. Exp. Med. 2004. 199: 1607-1618.
40. Ma, D. Y. and Clark, E. A., The role of CD40 and CD154/CD40L in dendritic cells. Semin. Immunol. 2009. 21: 265-272.
41. Gupta, S., Termini, J. M., Niu, L., Kanagavelu, S. K., Schmidtmayerova, H., Snarsky, V., Kornbluth, R. S. and Stone, G. W., EBV LMP1, a viral mimic of CD40, activates dendritic cells and functions as a molecular adjuvant when incorporated into an HIV vaccine. J. Leukoc. Biol. 2011. 90: 389-398.
42. Imbeault, M., Ouellet, M., Giguere, K., Bertin, J., Belanger, D., Martin, G. and Tremblay, M. J., Acquisition of host-derived CD40L by HIV-1 in vivo and its functional consequences in the B-cell compartment. J. Virol. 2011. 85: 2189-2200.
43. Ravi, V., Parida, S., Desai, A., Chandramuki, A., Gourie-Devi, M. and Grau, G. E., Correlation of tumor necrosis factor levels in the serum and cerebrospinal fluid with clinical outcome in Japanese encephalitis patients. J. Med. Virol. 1997. 51: 132-136.
44. Winter, P. M., Dung, N. M., Loan, H. T., Kneen, R., Wills, B., Thu le, T., House, D. et al., Proinflammatory cytokines and chemokines in humans with Japanese encephalitis. J. Infect. Dis. 2004. 190: 1618-1626.
45. Babu, G. N., Kalita, J. and Misra, U. K., Inflammatory markers in the patients of Japanese encephalitis. Neurol. Res. 2006. 28: 190-192.
46. Gupta, N. and Rao, P. V., Transcriptomic profile of host response in Japanese encephalitis virus infection. Virol. J. 2011. 8: 92.
47. Burke, D. S. and Morill, J. C., Levels of interferon in the plasma and cerebrospinal fluid of patients with acute Japanese encephalitis. J. Infect. Dis. 1987. 155: 797-799.
48. Singh, A., Kulshreshtha, R. and Mathur, A., Secretion of the chemokine interleukin-8 during Japanese encephalitis virus infection. J. Med. Microbiol. 2000. 49: 607-612.
49. Langenkamp, A., Messi, M., Lanzavecchia, A. and Sallusto, F., Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat. Immunol. 2000. 1: 311-316.
50. Smed-Sorensen, A., Lore, K., Walther-Jallow, L., Andersson, J. and Spetz, A. L., HIV-1-infected dendritic cells upregulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation. Blood 2004. 104: 2810-2817.
51. Buisson, S., Benlahrech, A., Gazzard, B., Gotch, F., Kelleher, P. and Patterson, S., Monocyte-derived dendritic cells from HIV type 1-infected individuals show reduced ability to stimulate T cells and have altered production of interleukin (IL)-12 and IL-10. J. Infect. Dis. 2009. 199: 1862-1871.
52. Waggoner, S. N., Hall, C. H. and Hahn, Y. S., HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL-12 production. J. Leukoc. Biol. 2007. 82: 1407-1419.
53. Khan, N., Rahim, S. S., Boddupalli, C. S., Ghousunnissa, S., Padma, S., Pathak, N., Thiagarajan, D. et al., Hydrogen peroxide inhibits IL-12 p40 induction in macrophages by inhibiting c-rel translocation to the nucleus through activation of calmodulin protein. Blood 2006. 107: 1513-1520.
54. Sanjabi, S., Hoffmann, A., Liou, H. C., Baltimore, D. and Smale, S. T., Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages. Proc. Natl. Acad. Sci. USA 2000. 97: 12705-12710.
55. Francisco, L. M., Sage, P. T. and Sharpe, A. H., The PD-1 pathway in tolerance and autoimmunity. Immunol. Rev. 2010. 236: 219-242.
56. Sharpe, A. H., Wherry, E. J., Ahmed, R. and Freeman, G. J., The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 2007. 8: 239-245.
57. Mueller, S. N., Vanguri, V. K., Ha, S. J., West, E. E., Keir, M. E., Glickman, J. N., Sharpe, A. H. and Ahmed, R., PD-L1 has distinct functions in hematopoietic and nonhematopoietic cells in regulating T cell responses during chronic infection in mice. J. Clin. Invest. 2010. 120: 2508-2515.
58. Urbani, S., Amadei, B., Tola, D., Massari, M., Schivazappa, S., Missale, G. and Ferrari, C., PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J. Virol. 2006. 80: 11398-11403.
59. Dong, H. and Chen, X., Immunoregulatory role of B7-H1 in chronicity of inflammatory responses. Cell. Mol. Immunol. 2006. 3: 179-187.
60. Schreiner, B., Mitsdoerffer, M., Kieseier, B. C., Chen, L., Hartung, H. P., Weller, M. and Wiendl, H., Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. J. Neuroimmunol. 2004. 155: 172-182.
61. + regulatory T cells. Proc. Natl. Acad. Sci. USA 2008. 105: 9331-9336.
62. Amarnath, S., Mangus, C. W., Wang, J. C., Wei, F., He, A., Kapoor, V., Foley, J. E. et al., The PDL1-PD1 axis converts human TH1 cells into regulatory T cells. Sci. Transl. Med. 2011. 3: 111-120.
63. Lu, L. F., Boldin, M. P., Chaudhry, A., Lin, L. L., Taganov, K. D., Hanada, T., Yoshimura, A. et al., Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 2010. 142: 914-929.
64. Vignali, D. A., Collison, L. W. and Workman, C. J., How regulatory T cells work. Nat. Rev. Immunol. 2008. 8: 523-532.
65. German, A. C., Myint, K. S., Mai, N. T., Pomeroy, I., Phu, N. H., Tzartos, J., Winter, P. et al., A preliminary neuropathological study of Japanese encephalitis in humans and a mouse model. Trans. R. Soc. Trop. Med. Hyg. 2006. 100: 1135-1145.
66. Johnson, R. T., Burke, D. S., Elwell, M., Leake, C. J., Nisalak, A., Hoke, C. H. and Lorsomrudee, W., Japanese encephalitis: immunocytochemical studies of viral antigen and inflammatory cells in fatal cases. Ann. Neurol. 1985. 18: 567-573.
67. Nie, H., Zheng, Y., Li, R., Guo, T. B., He, D., Fang, L., Liu, X. et al., Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-alpha in rheumatoid arthritis. Nat. Med. 2013. 19: 322-328.
68. hi T-regulatory cells. Blood 2006. 108: 253-261.
69. Gupta, N., Bhaskar, A. S. and Lakshmana Rao, P. V., Transcriptional regulation and activation of the mitogen-activated protein kinase pathway after Japanese encephalitis virus infection in neuroblastoma cells. FEMS Immunol. Med. Microbiol. 2011. 62: 110-121.